1170 related articles for article (PubMed ID: 32586214)
1. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications.
McFadyen JD; Stevens H; Peter K
Circ Res; 2020 Jul; 127(4):571-587. PubMed ID: 32586214
[TBL] [Abstract][Full Text] [Related]
2. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
[TBL] [Abstract][Full Text] [Related]
3. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
Ahmed S; Zimba O; Gasparyan AY
Clin Rheumatol; 2020 Sep; 39(9):2529-2543. PubMed ID: 32654082
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.
Bikdeli B; Madhavan MV; Jimenez D; Chuich T; Dreyfus I; Driggin E; Nigoghossian C; Ageno W; Madjid M; Guo Y; Tang LV; Hu Y; Giri J; Cushman M; Quéré I; Dimakakos EP; Gibson CM; Lippi G; Favaloro EJ; Fareed J; Caprini JA; Tafur AJ; Burton JR; Francese DP; Wang EY; Falanga A; McLintock C; Hunt BJ; Spyropoulos AC; Barnes GD; Eikelboom JW; Weinberg I; Schulman S; Carrier M; Piazza G; Beckman JA; Steg PG; Stone GW; Rosenkranz S; Goldhaber SZ; Parikh SA; Monreal M; Krumholz HM; Konstantinides SV; Weitz JI; Lip GYH;
J Am Coll Cardiol; 2020 Jun; 75(23):2950-2973. PubMed ID: 32311448
[TBL] [Abstract][Full Text] [Related]
5. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
Miesbach W; Makris M
Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
Bikdeli B; Madhavan MV; Gupta A; Jimenez D; Burton JR; Der Nigoghossian C; Chuich T; Nouri SN; Dreyfus I; Driggin E; Sethi S; Sehgal K; Chatterjee S; Ageno W; Madjid M; Guo Y; Tang LV; Hu Y; Bertoletti L; Giri J; Cushman M; Quéré I; Dimakakos EP; Gibson CM; Lippi G; Favaloro EJ; Fareed J; Tafur AJ; Francese DP; Batra J; Falanga A; Clerkin KJ; Uriel N; Kirtane A; McLintock C; Hunt BJ; Spyropoulos AC; Barnes GD; Eikelboom JW; Weinberg I; Schulman S; Carrier M; Piazza G; Beckman JA; Leon MB; Stone GW; Rosenkranz S; Goldhaber SZ; Parikh SA; Monreal M; Krumholz HM; Konstantinides SV; Weitz JI; Lip GYH;
Thromb Haemost; 2020 Jul; 120(7):1004-1024. PubMed ID: 32473596
[TBL] [Abstract][Full Text] [Related]
7. SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection.
Llau JV; Ferrandis R; Sierra P; Hidalgo F; Cassinello C; Gómez-Luque A; Quintana M; Amezaga R; Gero M; Serrano A; Marcos P
Rev Esp Anestesiol Reanim (Engl Ed); 2020; 67(7):391-399. PubMed ID: 32591185
[TBL] [Abstract][Full Text] [Related]
8. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses.
Mackman N; Antoniak S; Wolberg AS; Kasthuri R; Key NS
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2033-2044. PubMed ID: 32657623
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-Related Aortic Thrombosis: A Report of Four Cases.
Gomez-Arbelaez D; Ibarra-Sanchez G; Garcia-Gutierrez A; Comanges-Yeboles A; Ansuategui-Vicente M; Gonzalez-Fajardo JA
Ann Vasc Surg; 2020 Aug; 67():10-13. PubMed ID: 32474145
[TBL] [Abstract][Full Text] [Related]
10. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19.
D'Souza R; Malhamé I; Teshler L; Acharya G; Hunt BJ; McLintock C
Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1110-1120. PubMed ID: 32678949
[TBL] [Abstract][Full Text] [Related]
11. Coagulopathy of Coronavirus Disease 2019.
Iba T; Levy JH; Levi M; Connors JM; Thachil J
Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443
[TBL] [Abstract][Full Text] [Related]
12. [COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care].
Piera Carbonell A; Frías Vargas M; García Vallejo O; García Lerín A; Cabrera Ferriols MA; Peiró Morant J; Carrasco Carrasco E;
Semergen; 2020 Oct; 46(7):479-486. PubMed ID: 33046353
[TBL] [Abstract][Full Text] [Related]
13. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.
Merrill JT; Erkan D; Winakur J; James JA
Nat Rev Rheumatol; 2020 Oct; 16(10):581-589. PubMed ID: 32733003
[TBL] [Abstract][Full Text] [Related]
14. Malignant Cerebral Ischemia in A COVID-19 Infected Patient: Case Review and Histopathological Findings.
Patel SD; Kollar R; Troy P; Song X; Khaled M; Parra A; Pervez M
J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105231. PubMed ID: 33066910
[TBL] [Abstract][Full Text] [Related]
15. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia.
Costanzo L; Palumbo FP; Ardita G; Antignani PL; Arosio E; Failla G;
J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):711-716. PubMed ID: 32561465
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2.
Pamukçu B
Anatol J Cardiol; 2020 Oct; 24(4):224-234. PubMed ID: 33001051
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications.
Haimei MA
Clin Appl Thromb Hemost; 2020; 26():1076029620944497. PubMed ID: 32722927
[TBL] [Abstract][Full Text] [Related]
18. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19.
Godoy LC; Goligher EC; Lawler PR; Slutsky AS; Zarychanski R
CMAJ; 2020 Oct; 192(40):E1156-E1161. PubMed ID: 32816822
[No Abstract] [Full Text] [Related]
19. Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.
Parzy G; Daviet F; Puech B; Sylvestre A; Guervilly C; Porto A; Hraiech S; Chaumoitre K; Papazian L; Forel JM
Crit Care Med; 2020 Oct; 48(10):e971-e975. PubMed ID: 32618700
[TBL] [Abstract][Full Text] [Related]
20. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
